Just the Facts for 2002

Almost 19,000 employees work for the State of Iowa Executive Branch (excluding Fair Authority, Community-Based Corrections, and the Regents employees). These employees are undoubtedly the most valuable resource for providing timely and quality services to Iowans. To strategically manage this resource, State departments and policymakers must have thorough and accurate information. The information in “Just the Facts for 2002” is a snapshot of the workforce, collected, compiled, and presented in a format that will aid agencies and decision makers in strategic planning. In many cases, data cover a number of years and are presented to give the reader a sense of trends. While the Department of Personnel wants to present data in its purist form so readers can draw their own conclusions, we also have a responsibility to clarify anything that may be confusing or misleading . It is important to highlight workforce trends and explain their significance to the work of Iowa state government.

Just the Facts for 2003

Almost 19,000 employees work for the State of Iowa Executive Branch (excluding Fair Authority, Community-Based Corrections, and the Regents employees). These employees are undoubtedly the most valuable resource for providing timely and quality services to Iowans. To strategically manage this resource, State departments and policymakers must have thorough and accurate information. The information in “Just the Facts for 2003” is a snapshot of the workforce, collected, compiled, and presented in a format that will aid agencies and decision makers in strategic planning. In many cases, data cover a number of years and are presented to give the reader a sense of trends. While the Department of Personnel wants to present data in its purist form so readers can draw their own conclusions, we also have a responsibility to clarify anything that may be confusing or misleading . It is important to highlight workforce trends and explain their significance to the work of Iowa state government.

Just the Facts for 2005

Almost 19,000 employees work for the State of Iowa Executive Branch (excluding Fair Authority, Community-Based Corrections, and the Regents employees). These employees are undoubtedly the most valuable resource for providing timely and quality services to Iowans. To strategically manage this resource, State departments and policymakers must have thorough and accurate information. The information in “Just the Facts for 2005” is a snapshot of the workforce, collected, compiled, and presented in a format that will aid agencies and decision makers in strategic planning. In many cases, data cover a number of years and are presented to give the reader a sense of trends. While the Department of Personnel wants to present data in its purist form so readers can draw their own conclusions, we also have a responsibility to clarify anything that may be confusing or misleading . It is important to highlight workforce trends and explain their significance to the work of Iowa state government.

Just the Facts for 2006

Almost 19,000 employees work for the State of Iowa Executive Branch (excluding Fair Authority, Community-Based Corrections, and the Regents employees). These employees are undoubtedly the most valuable resource for providing timely and quality services to Iowans. To strategically manage this resource, State departments and policymakers must have thorough and accurate information. The information in “Just the Facts for 2006” is a snapshot of the workforce, collected, compiled, and presented in a format that will aid agencies and decision makers in strategic planning. In many cases, data cover a number of years and are presented to give the reader a sense of trends. While the Department of Personnel wants to present data in its purist form so readers can draw their own conclusions, we also have a responsibility to clarify anything that may be confusing or misleading . It is important to highlight workforce trends and explain their significance to the work of Iowa state government.

Botiga online

Botiga virtual en format web, feta amb arquitectura J2EE i treballada amb Struts2. S'ha utilitzat el PostgreSQL per tractar les dades en taules i HTML pel disseny de les pàgines web.

Aplicació de gestió d'un centre mèdic

L'objectiu del projecte és definir i desenvolupar un sistema de gestió d'un centre mèdic mitjançant un entorn web. Aquest sistema estarà format per una extranet que permetrà els clients visualitzar informació actualitzada de les especialitats que s'ofereixen i una intranet que permetrà realitzar diverses gestions referents a les visites que es produeixen en el centre.

L'examen clinique du sein : vidéos d'enseignement des compétences cliniques en gynécologie destinés à un module en ligne

Cette thèse présente un travail audiovisuel « L'examen clinique du sein ». Avec l'unité « L'examen génital » elle forme le module « Gynécologie » du projet Virtual Skills Lab (VSL). Le but du projet VSL est d'établir un portail d'enseignement en ligne pour l'enseignement des compétences cliniques (ce terme étant utilisé ici comme équivalent de l'anglais « clinical skills »). Les compétences traitées sont celles exigées par le Catalogue suisse des objectifs d'apprentissage. L'unité « L'examen clinique du sein » est constituée d'une multitude de courtes séquences vidéo qui peuvent être regardées à la suite ou de manière individuelle. Elle est divisée en étapes logiques telles que l'inspection ou la palpation. Chacune de ces étapes appelées « skill » est présentée de deux façons : comme vue d'ensemble et par une approche pas à pas. La séquence « vue d'ensemble » présente le skill en temps réel et représente donc une visualisation du but à atteindre par l'apprenant. Le skill est décomposé en petites étapes (step), les procédures sont montrées au ralenti, munies d'une explication par une voix off. Le format de ces séquences est présenté en double largeur, la partie de gauche montre l'action, la partie de droite est utilisée pour des tableaux ou des graphiques explicatifs. Les différents gestes des compétences cliniques sont rarement standardisés. Pour VSL, un processus de validation sur la base d'un consensus suisse a été mis en place. Ceci ne veut néanmoins pas dire que les modules VSL validés ont été intégrés dans le curriculum de toutes les universités suisses. Vu la complexité des curriculums et la multitude de facteurs entrant enjeu, notamment sur l'intégration des moyens d'enseignement audiovisuels, leur implémentation est une phase critique de tout projet de ce genre. En Suisse, le multilinguisme y ajoute un degré de complexité. A Lausanne, « L'examen clinique du sein » a été introduit aussi bien dans la formation pré- que postgraduée.

Characterization of Human Late Outgrowth Endothelial Progenitor-Derived Cells under Various Flow Conditions.

Background: Endothelial progenitor-derived cells (EPC) are a cell therapy tool in peripheral arterial disease and for re-endothelialization of bypasses and stents. Objective: To assess EPC behavior under flow conditions normally found in vivo. Results: EPC were isolated from human cord blood, cultured on compliant tubes and exposed in an in vitro flow system mimicking hemodynamic environments normally found in medium and large arteries. EPC exposed for 24 h to unidirectional (0.3 ± 0.1 or 6 ± 3 dynes/cm(2)) shear stress oriented along flow direction, while those exposed to bidirectional shear stress (0.3 ± 3 dynes/cm(2)) or static conditions had random orientation. Under bidirectional flow, tissue factor (TF) activity and mRNA expression were significantly increased (2.5- and 7.0-fold) compared to static conditions. Under low shear unidirectional flow TF mRNA increased 4.9 ± 0.5-fold. Similar flow-induced increases were observed for TF in mature umbilical vein-derived endothelial cells. Expression of tissue-type plasminogen activator (t-PA), urokinase (u-PA) and monocyte chemotactic protein 1 (MCP1) were reduced by 40-60% in late outgrowth endothelial progenitor-derived cells (LO-EPC) exposed to any flow environment, while MCP1, but not t-PA or u-PA, was decreased in HUVEC. Conclusions: Flow, in particular bidirectional, modifies the hemostatic balance in LO-EPC with increased TF and decreased plasminogen activator expression.

Grec 2370

ANTHEMIUS Trallianus. De admirabilibus machinis

Estratègies d'immbolització orientada d'anticossos per a la detecció directa en biosensors òptics: influència en la sensibilitat i especificitat

Els assajos de diagnòstic clínic i biomèdic requereixen tècniques de detecció sensibles, selectives i ràpides que permeten mesurar concentracions de substàncies directament de mostres biològiques com sang, orina o sèrum. Els dispositius biosensors compleixen en gran mesura aquests requisits i en particular, molts esforços van dirigits actualment al disseny de versions compactes de mida reduïda tipus "point of care" (POC) que permeten, per exemple, deslocalitzar les anàlisis dels hospitals i que proporcionen un seguiment del pacient més proper i eficient. Tot i així, la transferència d'aquestes tecnologies a dispositius miniaturitzats i portàtils amb aplicacions definides encara no està totalment assolida. Apart de les dificultats inherents a la integració de components electrònics, òptics, de distribució de líquids, etc. en un sistema menut i portàtil, un important repte en la miniaturització de biosensors és la biofuncionalització de la superfície sensora i la seua estabilitat una vegada s'han immobilitzat els reactius biològics. La detecció de biomarcadors proteics es duu a terme principalment mitjançant immunoassajos, basats en el reconeixement específic de la proteïna per part d'anticossos específics. En el cas de biosensors, el format directe, en el qual un anticòs s'immobilitza sobre la superfície sensora i la proteïna diana es detecta directament de la mostra, hauria de ser el format preferible. Tanmateix, és un dels menys eficients en termes d'estabilitat i sensibilitat, degut en part a la necessitat d'immobilitzar l'anticòs en una orientació adequada sense perjudicar l'afinitat per la molècula diana. En aquest treball s'ha fet un estudi comparatiu entre diferents metodologies d'immobilització d'anticossos sobre un transductor òptic i s'han desenvolupat i optimitzat diferents estratègies de bloqueig de superfície a fi d'obtindre un procediment robust, estable, aplicable a superfícies sensores de diferent naturalesa i que a més, permeta la detecció sensible i selectiva en mostres complexes.

Bases de datos XML nativas

Conèixer les diferents opcions a l'hora d'emmagatzemar dades i documents amb format XML. Familiaritzar-se amb els SGBD nadius i l'accés i maneig de la informació. Conèixer diferents formes d'accés al SGBD, conèixer les APIs disponible Centre en el llenguatge Java. Integració de tots els coneixements adquirits, desenvolupant una aplicació que accedeixi i gestioni dades emmagatzemades al SGBD.

Elaboració i presentació d’un pòster a una jornada de divulgació

Es pretén que els alumnes, en grups de dos o de forma individual, desenvolupin un problema relacionat amb l’assignatura “relativitat especial i ho presentin en format de pòster, primer a l’aula i desprès davant d’un públic aliè a l’assignatura, però amb certa formació i interès científic.

Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry.

The urinary steroid profile is constituted by anabolic androgenic steroids, including testosterone and its relatives, that are extensively metabolized into phase II sulfated or glucuronidated steroids. The use of liquid chromatography coupled to mass spectrometry (LC-MS) is an issue for the direct analysis of conjugated steroids, which can be used as urinary markers of exogenous steroid administration in doping analysis, without hydrolysis of the conjugated moiety. In this study, a sensitive and selective ultra high-pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometer (UHPLC-QTOF-MS) method was developed to quantify major urinary metabolites simultaneously after testosterone intake. The sample preparation of the urine (1 mL) was performed by solid-phase extraction on Oasis HLB sorbent using a 96-well plate format. The conjugated steroids were analyzed by UHPLC-QTOF-MS(E) with a single-gradient elution of 36 min (including re-equilibration time) in the negative electrospray ionization mode. MS(E) analysis involved parallel alternating acquisitions of both low- and high-collision energy functions. The method was validated and applied to samples collected from a clinical study performed with a group of healthy human volunteers who had taken testosterone, which were compared with samples from a placebo group. Quantitative results were also compared to GC-MS and LC-MS/MS measurements, and the correlations between data were found appropriate. The acquisition of full mass spectra over the entire mass range with QTOF mass analyzers gives promise of the opportunity to extend the steroid profile to a higher number of conjugated steroids.

5-Azacytidine to Treat Acute Myeloid Leukemia In Elderly or Frail Patients: A Phase II Study (SAKK 30/07).

Background: Acute Myeloid Leukemia (AML) in the elderly is notoriously difficult to treat and has a low remission rate with very few long term survivors when using standard treatment approaches. Azacytidine, a hypomethylating agent, has been shown to induce remission and prolong survival in patients with myelodysplastic syndromes; studying this approach to patients with AML is therefore warranted. We present results of an ongoing phase II trial treating elderly or frail AML patients with Azacytidine. Methods: AML elderly or frail patients, and therefore unfit for an intensive chemotherapy regimens, with a WHO performance status 3 were considered for this trial. Trial therapy consisted of 100mg/m2 of Azacytidine injected subcutaneously on 5 consecutive days every 28 days up to 6 cycles, stopping at 6 months if no hematological improvement achieved, or earlier in the case of progression or complications. Treatment was continued beyond 6 months in responding patients. Trial therapy was considered uninteresting if the response rate (CR + PR) within 6 months of therapy initiation was 15% or less and promising if 34% or more. Using the exact single-stage phase II design by A'Hern with a 5% significance level and 90% power, 43 patients were required: If 10 or fewer achieved a response within 6 months the trial therapy should not be considered for further investigation in its current format for this indication and patient population. Results: Between September 2008 and January 2010, 45 evaluable patients across 10 Swiss centers were accrued with a median follow-up of 7 months (range: 0 - 13). 27 (60%) were male, median age was 74 (range: 55 - 86) years and 35 (78.8%) had performance status 0-1. Patients had been excluded from more intensive chemotherapy regimens because of age (n = 37) or due to comorbidities or patient refusal (n=8). Five patients had therapy related AML. Patients received a median of 3 (range: 1 - 10) cycles. Treatment was stopped for not achieving a response by the 6th cycle in 2 patients and earlier in 26 patients (for disease progression in 5, toxicity in 3, patient refusal in 2, recurrent infections in 1, and death in 8). Seventeen patients remain on therapy. The median time spent in the hospital was 12 days (1 - 30) in 24/38 patients hospitalized during the first treatment cycle and 13 days (2 - 28) in 15/31 patients hospitalized during subsequent cycles. Adverse events of grade III or higher most frequently reported were constitutional or hematologic, i.e. fatigue in 5, febrile neutropenia in 8, infections in 6, dyspnea in 6, anemia in 3, neutropenia in 12 and thrombocytopenia in 10, hemorrhage in 2 and retinal detachment in 5. Based on available data on 38 patients, CR/CRi or hematologic improvement or stable disease within 6 months of trial registration was observed in a proportion of patients. Final and mature data, determining whether the predefined proportion of responding patients has been reached or not, will be presented at the conference. Up to now there were a total of 26 deaths. Median overall survival time was 5.7 months (95% CI: 3.1, 8.7). Conclusions: The current results of this slightly modified Azacytidine schedule demonstrate a feasible new therapy option for elderly or frail AML patients in an outpatient setting with moderate, mainly hematologic toxicity.

Preservació digital al núvol

Ara que ja ningú qüestiona les publicacions digitals, l'accés obert o els repositoris de tipus institucional o temàtic, cal co-mençar a treballar en els temes de preservació. Som responsables d'assegurar l'accés i l'ús futurs dels documents digitals, hagin nascut en format digital o siguin fruit dels projectes de digitalització. En aquest article es parla sobre la preservació digital i els tipus de continguts, així com els conceptes, tipologies, costos i usos de l'anomenat «núvol». També es mostra un exemple de núvol privat, la preservació de tesis doctorals del TDX i es comenta una experiència de núvol públic, el DuraCloud.